IL146090A0 - A synthetic gene for expression of a retroviral protein with wild type activity in eukaryotic cells - Google Patents
A synthetic gene for expression of a retroviral protein with wild type activity in eukaryotic cellsInfo
- Publication number
- IL146090A0 IL146090A0 IL14609000A IL14609000A IL146090A0 IL 146090 A0 IL146090 A0 IL 146090A0 IL 14609000 A IL14609000 A IL 14609000A IL 14609000 A IL14609000 A IL 14609000A IL 146090 A0 IL146090 A0 IL 146090A0
- Authority
- IL
- Israel
- Prior art keywords
- expression
- wild type
- eukaryotic cells
- synthetic gene
- type activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99201306 | 1999-04-26 | ||
EP00200171 | 2000-01-18 | ||
PCT/EP2000/003765 WO2000065076A2 (en) | 1999-04-26 | 2000-04-26 | Synthetic gene for expressing active retroviral protein in eukaryotes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146090A0 true IL146090A0 (en) | 2002-07-25 |
Family
ID=26071747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14609000A IL146090A0 (en) | 1999-04-26 | 2000-04-26 | A synthetic gene for expression of a retroviral protein with wild type activity in eukaryotic cells |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1183381A2 (xx) |
JP (1) | JP2002542791A (xx) |
AU (1) | AU778106B2 (xx) |
BR (1) | BR0010077A (xx) |
CA (1) | CA2369058A1 (xx) |
HU (1) | HUP0201019A2 (xx) |
IL (1) | IL146090A0 (xx) |
NO (1) | NO20015168L (xx) |
PL (1) | PL351988A1 (xx) |
RU (1) | RU2001131728A (xx) |
WO (1) | WO2000065076A2 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US6656706B2 (en) * | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
ES2329648T3 (es) * | 1999-12-23 | 2009-11-30 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Clones moleculares con genes mutados gag/pol de vih, gag de vis y env de vis. |
AUPQ580300A0 (en) * | 2000-02-23 | 2000-03-16 | National Cancer Centre Of Singapore Pte Ltd | Genetic analysis |
GB0009760D0 (en) * | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
US6835568B2 (en) | 2001-10-30 | 2004-12-28 | Virxsys Corporation | Regulated nucleic acid expression system |
AU2004236536A1 (en) * | 2003-05-06 | 2004-11-18 | National Institute Of Advanced Industrial Science And Technology | Multiple gene transcription activity determining sysyem |
WO2007042169A2 (en) * | 2005-10-07 | 2007-04-19 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Matrix metalloproteinase 11 vaccine |
JP6824594B2 (ja) | 2014-09-11 | 2021-02-03 | Jnc株式会社 | 合成遺伝子の設計方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468629A (en) * | 1993-04-13 | 1995-11-21 | Calhoun; Cornelia | Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein |
US5434065A (en) * | 1993-05-06 | 1995-07-18 | President And Fellows Of Harvard College | In vivo selection of microbial virulence genes |
US5811270A (en) * | 1994-05-20 | 1998-09-22 | Grandgenett; Duane P. | In vitro method for concerted integration of donor DNA molecules using retroviral integrase proteins |
US6200811B1 (en) * | 1996-04-02 | 2001-03-13 | The Regents Of The University Of California | Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein |
US6114148C1 (en) * | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
ES2274566T3 (es) * | 1997-02-07 | 2007-05-16 | MERCK & CO., INC. | Genes gag del vih sinteticos. |
US6602705B1 (en) * | 1998-12-31 | 2003-08-05 | Chiron Corporation | Expression of HIV polypeptides and production of virus-like particles |
AU2487300A (en) * | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
-
2000
- 2000-04-26 HU HU0201019A patent/HUP0201019A2/hu unknown
- 2000-04-26 AU AU45579/00A patent/AU778106B2/en not_active Ceased
- 2000-04-26 BR BR0010077-3A patent/BR0010077A/pt not_active Application Discontinuation
- 2000-04-26 CA CA002369058A patent/CA2369058A1/en not_active Abandoned
- 2000-04-26 WO PCT/EP2000/003765 patent/WO2000065076A2/en active IP Right Grant
- 2000-04-26 RU RU2001131728/15A patent/RU2001131728A/ru unknown
- 2000-04-26 PL PL00351988A patent/PL351988A1/xx unknown
- 2000-04-26 JP JP2000614410A patent/JP2002542791A/ja not_active Withdrawn
- 2000-04-26 IL IL14609000A patent/IL146090A0/xx unknown
- 2000-04-26 EP EP00927069A patent/EP1183381A2/en not_active Withdrawn
-
2001
- 2001-10-23 NO NO20015168A patent/NO20015168L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4557900A (en) | 2000-11-10 |
RU2001131728A (ru) | 2004-02-20 |
CA2369058A1 (en) | 2000-11-02 |
HUP0201019A2 (en) | 2002-08-28 |
NO20015168D0 (no) | 2001-10-23 |
PL351988A1 (en) | 2003-07-14 |
AU778106B2 (en) | 2004-11-18 |
BR0010077A (pt) | 2002-01-15 |
WO2000065076A3 (en) | 2001-12-13 |
NO20015168L (no) | 2001-12-14 |
WO2000065076A2 (en) | 2000-11-02 |
EP1183381A2 (en) | 2002-03-06 |
JP2002542791A (ja) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1192244E (pt) | Células vegetais e plantas geneticamente modificadas possuindo uma maior actividade de uma proteína amilosucrase e de uma enzima ramificadora | |
AU5734998A (en) | Embryonic stem cell serum replacement | |
AU4376497A (en) | An enzyme with amylase activity | |
AU3419200A (en) | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same | |
AU2576699A (en) | Erythropoietin with altered biological activity | |
AU1201600A (en) | Controlling gene expression in living cells | |
IL146090A0 (en) | A synthetic gene for expression of a retroviral protein with wild type activity in eukaryotic cells | |
AU2578899A (en) | Multimeric erythropoietin with altered biological activity | |
AU6056501A (en) | Measurements of enzymatic activity in a single, individual cell in population | |
AU2878600A (en) | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells | |
PL337942A1 (en) | Isolated genes of dendricall cell membranic proteins | |
IL139739A0 (en) | Polypeptides with beta-secretase type activity | |
EP0973867A4 (en) | CELL CULTURE MEDIA FOR INCREASED PROTEIN PRODUCTION | |
GB9714936D0 (en) | Cell culture products | |
AU2656800A (en) | Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity | |
AU7494200A (en) | Proteins associated with cell differentiation | |
AU3366099A (en) | Drm, a secreted protein with cell growth inhibiting activity, and related methods and compositions | |
GB2314332B (en) | Gene expression in mammalian cells | |
EP1072682A4 (en) | PROTEIN AND GENE PARTICIPATING IN THE DIFFERENTIATION OF IMMORTALIZED CELLS | |
AU7106398A (en) | Automated external defibrillator battery memory, dual cell, and removable configurations | |
AU3054899A (en) | Cell line not expressing beta-secretase activity | |
GB2331750B (en) | Gene for a cell wall lytic enzyme | |
HU230003B1 (en) | Bisindolylmaleimides with inhibitory activity on cell proliferation | |
AU8999298A (en) | Protein having activity of activiting nerve cell functions | |
EP1051915A4 (en) | FERMENTED ORGANIC ACID MODIFYING CELL AND PROTEIN FUNCTIONS |